NCR1 and acute myeloid leukemia: Injection of additional Ncr1+/+ ILC1s into Ncr1+/+ mice that were transplanted with C1498-Luc AML cells prolonged survival compared to control mice who were not provided with additional Ncr1+/+ ILC1 cells (Fig. 5k), supporting the notion that ILC1s play a role in anti-AML responses in vivo.